|
|
 |
|
Viewing report
|
|
|
|
Molecular Pathology in Drug Discovery and Development
John Wiley and Sons Ltd, Aug 2009, Pages: 349
Covers powerful new tools for drug development
Molecular pathology offers tools and techniques that can greatly enhance the drug discovery and development process, helping to make the promises of personalized medicine a reality. Molecular Pathology in Drug Discovery and Development provides an unmatched guide to this cutting-edge discipline and its applications to pharmaceutical science.
With contributions from leading lights in drug discovery, drug development, and molecular pathology balanced by a consistent editorial approach, this reference offers both an overview of molecular pathology and a close look at the methods as they are applied to the process of drug discovery and development. Presented as steps in the drug development process, the coverage includes the use of molecular pathology to:
- Identify and validate new drug candidates
- Enhance transcriptional profiling to better find and validate biomarkers
- Assess toxicology
- Employ toxicogenomics to identify genes relevant to the safety of compounds
- Identify correct doses for different drugs
- Identify patients for treatment
- Develop molecular therapies
- Further the new techniques of Immunohistochemistry and Immunofluorescence
With many tests and treatments already working today, drug research and development using molecular pathology has shown itself an extremely fruitful area. Molecular Pathology in Drug Discovery and Development gives practitioners an up-to-date resource on this highly active discipline and its role in furthering pharmaceutical research
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
The Executive Guide to Molecular Imaging
Drug Discovery Research: New Frontiers in the Post-Genomic Era
Drug Target Analytical Report: HCRTR1 - An Insight into Pathways, Disease Associations, Competitive Landscape, Chemotypes, Discovery Pipeline, and Marketed Drugs
Drug Target Analytical Report: HCRTR2 - An Insight into Pathways, Disease Associations, Competitive Landscape, Chemotypes, Discovery Pipeline, and Marketed Drugs
The Emerging Drug Targets Outlook: An Analysis of Novel Molecular Targets To Develop Innovative New Therapeutics
Target Analytical Report - ABL1
Translational Medicine: Assessing the Feasibility and Challenges
Target Analytical Report - CCKBR
Mitochondria, 2nd Edition
Alzheimer Disease - New Drugs, Markets and Companies
Oxford Handbook of Flow Cytometry for Biotechnology
Tissue MicroArrays: Emerging Business Opportunities and Applications Driving the Marketplace
|
|
|
|
